Vivtex and Nimbus Therapeutics are working with big pharma to develop the next wave of oral obesity treatments.

Continuing with the rare disease theme (Rare Disease Day is Feb 28), Elisabeth Gardiner of Tevard Biosciences explains in a video interview that research into ultra-rare conditions continues to yield ...

An expert panel formed to recommend changes has submitted its final report, and the Centre has now issued an office order assigning specific reforms to concerned divisions of CDSCO ...

Against the backdrop of Rare Disease Day advocates visiting Capitol Hill this week, a Senate panel raised alarm on Thursday ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Connecticut’s legal market is artificially constrained by a limitation that neither improves safety nor reflects how cannabis ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

A push to change Washington's controversial "Keeping Families Together Act" fell short in this year's legislative session.

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...

A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...